Time to deterioration as measure for symptom burden and quality of life – Data from the LuLife project in 507 patients with non-small cell lung cancer in Germany. 7. Juni 2016 von Verschuer, U., Sandner, R., Tessen, H.-W., Emde, T.-O., Schnitzler, M., Binninger, A., Jänicke, M., Marschner, N., 2016. Oncol Res Treat 39 (suppl 3)(V986), 303. doi:10.1159/000449050 Abstract Prophylaxis of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with lung cancer: results from an interim analysis of the non-interventional study NADIR. Potthoff, K., Lück, A., Frost, N., Losem, C., Weide, R., Schulz, H., 2016. Oncol Res Treat 39 (suppl3)(P949), 292. doi:10.1159/000449050… Weiterlesen Systemic palliative treatment in patients with metastatic colorectal cancer tested for their (K)RAS mutation status – Real-life data from the clinical Tumour Registry Colorectal Cancer (TKK). Zahn, M.-O., Schnell, R., Karcher, A., Schnitzler, M., Wetzel, N., Fleitz, A., Marschner, N., 2016. Oncol Res Treat 39(suppl5)(V171), 42. ddoi:10.1159/000449050… Weiterlesen